Answers are grounded in this paper and cite their sources.
The statistical analysis of our data regarding to the association between RB1 deletion and deletion type, TTFT, disease stage, and OS has not confirmed type II deletion or biallelic deletion cause poor prognosis. However, our data supports the deletion burden has a prognostic effect. More studies are needed to elucidate the cause of the clinical heterogeneity of CLL cases with del(13q).
No takes yet. Share an insight, caveat, or question.
Aras et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: